Skip to main content

Find Clinical Trials

Home
Conditions
Cutaneous T-Cell Lymphoma Refractory

Clinical trial condition

Cutaneous T-Cell Lymphoma Refractory

Explore clinical trials studying Cutaneous T-Cell Lymphoma Refractory. Study availability and eligibility vary by location and protocol.

2 public trials 1 recruiting study

Refine in advanced search Browse all conditions

Cutaneous T-Cell Lymphoma Refractory trial results

Recruiting

Duvelisib and Venetoclax in Patients With Relapsed or Refractory Peripheral T-cell Lymphoma (PTCL)

NCT06810778

Conditions: Cutaneous T-Cell Lymphoma Refractory, Disease Attributes, Hematologic Diseases, +16 more
Locations: David Geffen School of Medicine at the University of California at Los Angeles Los Angeles, California, United States

View Trial Details

Not Yet Recruiting

Aclarubicin Plus Cyclophosphamide, Vincristine, and Prednisone (CAOP) in Patients With Previously Treated Cutaneous T-cell Lymphoma

NCT07535710

Conditions: Cutaneous T Cell Lymphoma (CTCL), Cutaneous T-Cell Lymphoma Refractory, Cutaneous T-Cell Lymphoma, Relapsed, +16 more
Locations: Ruijin Hospital Affiliated to Shanghai Jiao Tong University School of Medicine, Shanghai Shanghai, China

Ruijin Hospital Wuxi Branch Wuxi, China

View Trial Details